Actuate Therapeutics competitors and similar companiesClear all
Actuate Therapeutics's competitors and similar companies include GlycoMimetics, Corvus Pharmaceuticals, Immunovative Therapies and Luye Pharma.
 Actuate Therapeutics Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. |  Immunovative Therapies Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases. |  Luye Pharma Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications. | |
Founding Date | Founding Date 2015 | Founding Date 2003 | Founding Date 2014 | Founding Date 2004 | Founding Date 1994 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Fort Worth, US HQ Dublin, IE | Locations Rockville, US HQ | Locations Burlingame, US HQ | Locations Jerusalem, IL HQ | Locations CN HQ |
Employees | Employees 811% decrease | Employees 5025% increase | Employees 4911% decrease | Employees 11 | Employees 5,0054% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 123.4 m | Valuation ($) 141.6 m | Valuation ($) N/A | Valuation ($) N/A |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.8 | Employee Rating N/A | Employee Rating N/A |
Financial | |||||
Net income | Net income N/A | Net income ($46.7m) (FY, 2022) | Net income ($41.3m) (FY, 2021) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 31.2m | Total funding raised $ 101.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View companyCorvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
View companyImmunovative Therapies
HQ
Jerusalem, IL
Employees
11
Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.
View companyLuye Pharma
HQ
CN
Employees
5,005↑ 4% increase
Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.
View company